- Home
- HOLO vs PDSB Comparison
HOLO vs PDSB Comparison
Compare HOLO & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOLO
- PDSB
- Stock Information
- Founded
- HOLO 2018
- PDSB 2005
- Country
- HOLO China
- PDSB United States
- Employees
- HOLO N/A
- PDSB N/A
- Industry
- HOLO Computer Software: Programming Data Processing
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- HOLO Technology
- PDSB Health Care
- Exchange
- HOLO Nasdaq
- PDSB Nasdaq
- Market Cap
- HOLO 66.3M
- PDSB 72.2M
- IPO Year
- HOLO N/A
- PDSB N/A
- Fundamental
- Price
- HOLO $4.46
- PDSB $1.20
- Analyst Decision
- HOLO
- PDSB Strong Buy
- Analyst Count
- HOLO 0
- PDSB 2
- Target Price
- HOLO N/A
- PDSB $10.00
- AVG Volume (30 Days)
- HOLO 1.5M
- PDSB 582.9K
- Earning Date
- HOLO 01-01-0001
- PDSB 08-13-2025
- Dividend Yield
- HOLO N/A
- PDSB N/A
- EPS Growth
- HOLO N/A
- PDSB N/A
- EPS
- HOLO 13.81
- PDSB N/A
- Revenue
- HOLO $44,840,587.00
- PDSB N/A
- Revenue This Year
- HOLO N/A
- PDSB N/A
- Revenue Next Year
- HOLO N/A
- PDSB N/A
- P/E Ratio
- HOLO $0.32
- PDSB N/A
- Revenue Growth
- HOLO 37.10
- PDSB N/A
- 52 Week Low
- HOLO $4.16
- PDSB $0.85
- 52 Week High
- HOLO $375.20
- PDSB $4.29
- Technical
- Relative Strength Index (RSI)
- HOLO 44.14
- PDSB 47.89
- Support Level
- HOLO $4.42
- PDSB $1.15
- Resistance Level
- HOLO $5.06
- PDSB $1.31
- Average True Range (ATR)
- HOLO 0.31
- PDSB 0.09
- MACD
- HOLO 0.01
- PDSB 0.00
- Stochastic Oscillator
- HOLO 19.35
- PDSB 15.63
About HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.